Literature DB >> 17651754

HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.

Isabel Olivares1, Alok Mulky, Peter I Boross, József Tözsér, John C Kappes, Cecilio López-Galíndez, Luis Menéndez-Arias.   

Abstract

Mature enzymes encoded within the human immunodeficiency virus type 1 (HIV-1) genome (protease (PR), reverse transcriptase (RT) and integrase (IN)) derive from proteolytic processing of a large polyprotein (Gag-Pol). Gag-Pol processing is catalyzed by the viral PR, which is active as a homodimer. The HIV-1 RT functions as a heterodimer (p66/p51) composed of subunits of 560 and 440 amino acid residues, respectively. Both subunits have identical amino acid sequence, but p51 lacks 120 residues that are removed by the HIV-1 PR during viral maturation. While p66 is the catalytic subunit, p51 has a primarily structural role. Amino acid substitutions affecting the stability of p66/p51 (i.e. F130W) have a deleterious effect on viral fitness. Previously, we showed that the effects of F130W are mediated by p51 and can be compensated by mutation T58S. While studying the dynamics of emergence of the compensatory mutation, we observed that mutations in the viral PR-coding region were selected in HIV clones containing the RT substitution F130W, before the imposition of T58S/F130W mutations. The PR mutations identified (G94S and T96S) improved the replication capacity of the F130W mutant virus. By using a trans-complementation assay, we demonstrate that the loss of p66/p51 heterodimer stability caused by Trp130 can be attributed to an increased susceptibility of RT to viral PR degradation. Recombinant HIV-1 PRs bearing mutations G94S or T96S showed decreased dimer stability and reduced catalytic efficiency. These results were consistent with crystallographic data showing the location of both residues in the PR dimerization interface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651754      PMCID: PMC2696282          DOI: 10.1016/j.jmb.2007.06.073

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  53 in total

1.  Autoprocessing of HIV-1 protease is tightly coupled to protein folding.

Authors:  J M Louis; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1999-09

Review 2.  Retroviral proteinases.

Authors:  S Oroszlan; R B Luftig
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.

Authors:  E M Wondrak; J M Louis
Journal:  Biochemistry       Date:  1996-10-01       Impact factor: 3.162

5.  Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.

Authors:  J Tözsér; I Bláha; T D Copeland; E M Wondrak; S Oroszlan
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

6.  The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.

Authors:  Joeri Auwerx; Joke Van Nieuwenhove; Fátima Rodríguez-Barrios; Sonia de Castro; Sonsoles Velázquez; Francesca Ceccherini-Silberstein; Erik De Clercq; María-José Camarasa; Carlo-Federico Perno; Federico Gago; Jan Balzarini
Journal:  FEBS Lett       Date:  2005-04-25       Impact factor: 4.124

7.  Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.

Authors:  Alok Mulky; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

8.  The beta7-beta8 loop of the p51 subunit in the heterodimeric (p66/p51) human immunodeficiency virus type 1 reverse transcriptase is essential for the catalytic function of the p66 subunit.

Authors:  P K Pandey; N Kaushik; T T Talele; P N Yadav; V N Pandey
Journal:  Biochemistry       Date:  2001-08-14       Impact factor: 3.162

9.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

10.  Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323.

Authors:  S Erickson-Viitanen; R M Klabe; P G Cawood; P L O'Neal; J L Meek
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

View more
  8 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.

Authors:  Krisztina Matúz; János Mótyán; Mi Li; Alexander Wlodawer; József Tőzsér
Journal:  FEBS J       Date:  2012-08-17       Impact factor: 5.542

Review 3.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

4.  Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.

Authors:  Gilberto Betancor; Maria C Puertas; María Nevot; César Garriga; Miguel A Martínez; Javier Martinez-Picado; Luis Menéndez-Arias
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

5.  Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease.

Authors:  Linda L Dunn; Paul L Boyer; Patrick K Clark; Stephen H Hughes
Journal:  Virology       Date:  2013-07-11       Impact factor: 3.616

6.  Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions.

Authors:  Linda L Dunn; Mary Jane McWilliams; Kalyan Das; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

7.  The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogs.

Authors:  Zandrea Ambrose; Brian D Herman; Chih-Wei Sheen; Shannon Zelina; Katie L Moore; Gilda Tachedjian; Dwight V Nissley; Nicolas Sluis-Cremer
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

8.  Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases.

Authors:  János András Mótyán; Márió Miczi; József Tőzsér
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.